TEMODAR 250 mg Logo Pill - white capsule/oblong, 21mm
Generic Name: temozolomide
Pill with imprint TEMODAR 250 mg Logo is White, Capsule/Oblong and has been identified as Temodar Temozolomide 250 mg. It is supplied by Schering.
Temodar is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temodar Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEMODAR 250 mg Logo
![Temodar Temozolomide 250 mg TEMODAR 250 mg Logo](https://www.drugs.com/images/pills/mtm/000851417_PB.jpg)
![Temodar Temozolomide 250 mg TEMODAR 250 mg Logo](https://www.drugs.com/images/pills/nlm/000851417.jpg)
Temodar
- Generic Name
- temozolomide
- Imprint
- TEMODAR 250 mg Logo
- Strength
- Temozolomide 250 mg
- Color
- White
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schering
- Inactive Ingredients
-
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
water,
ammonia,
potassium hydroxide,
ferric oxide red,
titanium dioxide,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00085-1417 (Discontinued) | Schering-Plough Corporation |
54868-5354 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about Temodar (temozolomide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- En español
Patient resources
- Temodar drug information
- Temodar (Temozolomide Intravenous) (Advanced Reading)
- Temodar (Temozolomide Oral) (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.